M. Kaplan

Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

Charles D. Ellis, T. Ikizler, Pingsheng Wu, 2014, Journal of the American Society of Nephrology : JASN.

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.

F. Locatelli, M. Chonchol, H. Abboud, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients.

M. H. Schwenk, W. K. Bolton, M. Kaplan, 2005, Kidney international.

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.

H. Jüppner, D. Sherrard, W. Goodman, 2005, Kidney international.

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

H. Malluche, W. Goodman, J. Coburn, 2008, Clinical nephrology.

Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.

J. Lewis, M. Koury, M. Kaplan, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial.

L. Ploughman, D. Haas, H. Kessler, 2001, The Journal of infectious diseases.

292 A Dose-Ranging and Efficacy Phase 3 Trial of Ferric Citrate (FC) as a Phosphate Binder in Dialysis Patients

J. Lewis, M. Kaplan, G. Schulman, 2011 .

Predictive factors of complications and 30-day mortality in patients undergoing percutaneous endoscopic gastrostomy: the utility of C-reactive protein to albumin ratio.

A. Tanoğlu, M. Kaplan, Y. Yazgan, 2021, Acta gastro-enterologica Belgica.

Association between Kelch-like ECH-associated protein-1 and GRACE risk score in non-ST elevation myocardial infarction.

M. Kaplan, G. Altunbas, Emre Kaya, 2023, European review for medical and pharmacological sciences.